Earnings History Data for Neumora Therapeutics, Inc. (NMRA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Neumora Therapeutics, Inc.
Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. Its therapeutic pipeline currently consists of clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Neumora Therapeutics Inc. is based in WATERTOWN, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | PM | NMRA | Neumora Therapeutics, Inc. | 2,170 | -0.45 | -0.38 | -1.14 | Neumora Therapeutics GAAP EPS of -$0.45 misses by $0.06 [11/12/2024 8:32 AM] |
11.37 | -2.27 (-16.64%) |
13.26 | -0.38 (-2.79%) |
8.33 - 21.00 | 1,384,162 | 1,100,000 | 435 | ||
| 07-05-2024 | PM | NMRA | Neumora Therapeutics, Inc. | 1,475 | -0.34 | -0.35 | 0.00 | Neumora Therapeutics GAAP EPS of -$0.34 [5/7/2024 8:07 AM] |
9.81 | 0.46 (4.92%) |
0.0 | 0.0 (0.00%) |
8.82 - 21.00 | 453,329 | 550,000 | 0 | ||
| 01-11-2023 | PM | NMRA | Neumora Therapeutics, Inc. | 1,667 | -1.14 | -0.48 | 0.00 | Neumora Therapeutics GAAP EPS of -$1.14 misses by $0.74 [11/1/2023 11:24 AM] |
10.79 | -0.13 (-1.19%) |
0.0 | 0.0 (0.00%) |
9.35 - 17.74 | 120,079 | 290,000 | 0 | ||